BRIDGE PrEP
Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: a qualitative study.
Allen ST, et al. AIDS Behav. 2020;24(6):1942-1950.
Successful integration of HIV PrEP in primary care and women's health clinical practice: a model for implementation.
Casey E, et al. Viruses. 2023;15(6):1365.
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.
Integrating HIV Preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the Project SHE Demonstration Study.
Roth AM, et al. J Acquir Immun Defic Syndr. 2021;86(3):e61-e70.
Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.
Shrestha R, et al. J Subst Abuse Treat. 2020;117:108058.
Downloadable Resources
Patient Education Poster
Empower patients to lower their risk of acquiring HIV with a patient education poster.
Patient Education Brochure
Educate patients about PrEP options and coverage with this patient education brochure.
Clinician Pocket Guide
Keep information on how to initiate PrEP at your fingertips with this comprehensive clinician pocket guide.
Clinical Practice Guidelines
Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update). A clinical practice guideline.
US Public Health Service. Centers for Disease Control and Prevention; 2021.
Sexually transmitted infections treatment guidelines, 2021.
Centers for Disease Control and Prevention. Last reviewed July 2021.
CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024.
Bachmann LH, et al. MMWR Recomm Rep. 2024;73(2);1-8.
Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016.
CDC Stacks. Centers for Disease Control and Prevention; last updated May 2018.
Professional Organizations and & Resources
AIDS Education & Training Center (AETC) Program: National Coordinating Resource Center
Provides consultation, training, and resources nationwide.
Ending the HIV epidemic: Ready, Set, PrEP!
US Department of Health and Human Services.
Find services.
AIDSVu.
The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health.
Makadon HJ, et al, American College of Physicians (ACP), eds. 2nd ed. Boston, MA: Fenway Health; 2015.
HIV Language Guide.
National Institute of Allergy and Infectious Diseases.
Injection drug use.
Centers for Disease Control and Prevention; March 2022.
Clinical Testing Guidance for HIV.
Centers for Disease Control and Prevention; April 2024.
Please PrEP Me
Both professional and patient resources as well as a state-by-state list of PrEP resources in all 50 states.
The six EHE [Ending the HIV Epidemic in the U.S.] indicators.
America’s HIV Epidemic Analysis Dashboard; March 2024.
SAMHSA (Substance Abuse and Mental Health Services) provides an interactive national map that facilitates identification of local resources and services for substance use and mental health disorders.
Harm Reduction Locations; 2024.
Patient Resources
About HIV.
Centers for Disease Control and Prevention; January 2024.
HIV resources.
National Institutes of Health, Office of AIDS Research; October 2022.
Patient Assistance Programs for medication coverage:
Ready, Set, PrEP!
Or call: 855-447-8410
Truvada and Descovy: Advancing Access Patient Assistance Program
Truvada and Descovy: Advancing Access
Or call: 1-877-505-6986
Apretude: ViiV Connect
BRIDGE PrEP
Building Bridges to Reach People Who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
| Faculty: | Gregory Felzien, MD, AAHIVS |
| Release: | 12/21/2022 |
| Expiration: | 12/20/2023 |
